Uveal Melanoma
📧 Sign up to get email alerts when something new happens for Uveal Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2018-07-18Clinical Trial Update: Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating Glembatumumab Vedotin in combination with nivolumab and ipilimumab for advanced, unresectable solid tu…
-
CLINICAL_TRIALS withdrawal · 2018-06-26Clinical Trial Update: Validation of a Molecular Prognostic Test for Eye Melanoma
A clinical trial validating a molecular prognostic test for eye melanoma has been withdrawn. The sponsor is Washington University School of …
-
CLINICAL_TRIALS withdrawal · 2017-12-12Clinical Trial Update: Efficacy and Safety Study of GSK1120212, a MEK Inhibitor, in Subjects With Uveal Melanoma [Phase 2]
A Phase 2 clinical trial evaluating the MEK inhibitor GSK1120212 in patients with uveal melanoma has been withdrawn.